Home › NCT05786664

Breast Cancer Survivorship Biorepository

A Comprehensive Breast Cancer Survivorship Biorepository

Who can join

Ages 18 and older · Women

Inclusion Criteria:

* Women of all racial and ethnic groups 18 years of age or older
* Women with a diagnosis of invasive breast cancer (stages I-III) within the past 7 years
* Women who have completed active treatment for breast cancer (surgery, chemotherapy, HER2-directed therapy and radiation)
* Prior participation on clinical trials is allowed

Exclusion Criteria:

* Current receipt of interventional clinical trial participation
* Stage IV (metastatic) cancer
* Prior history of recurrence (except recurrence following ductal carcinoma in situ)
* Inability to give informed consent
* Unable to speak English, Spanish, Chinese, or Korean

About the study

This study collects blood samples as well as clinical and self-report data from stage I-III breast cancer survivors to create a biorepository for future use. The creation of this biorepository will allow for future research into links between individual, molecular, and genomic signatures and cancer outcomes.

What is being tested

• Biospecimen Collection (procedure)
• Electronic Health Record Review (other)
• Quality-of-Life Assessment (other)
• Survey Administration (other)

Sponsor: University of Southern California · Participants: 1,300 · Started: Apr 11, 2022

Contact the study team

• Audrey Saghian, MPH · Phone: 323-865-6086

Official record on ClinicalTrials.gov — NCT05786664

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.